Open AccessAntibiotics Combinations and Chitosan Nanoparticles for Combating Multidrug Resistance Acinetobacter baumannii
Author(s) -
Nancy G Banoub,
Sarra E. Saleh,
Hala S Helal,
Khaled M. Aboshanab
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s328788
Subject(s) - acinetobacter baumannii , tigecycline , colistin , broth microdilution , meropenem , microbiology and biotechnology , antibiotics , multiple drug resistance , antimicrobial , antibiotic resistance , drug resistance , medicine , minimum inhibitory concentration , biology , bacteria , pseudomonas aeruginosa , genetics
Successful treatment of Acinetobacter (A.) baumannii -associated infection is complicated by the emergence of multidrug resistance (MDR), particularly in clinical settings. This urges searching for new alternatives to encounter such health problem.